Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00313404 · ClinicalTrials.gov registry record · NA

Infectivity of Norovirus in Groundwater-Human Challenge Study

A NA study of Healthy, sponsored by Emory University.

Completed
Registry status
NA
Development phase
13
Enrollment target
1
Study location

NCT00313404: Completed NA study of Healthy, sponsored by Emory University.

NCT00313404 is a NA study of Healthy that has completed, run by Emory University. The registered enrollment target is 13 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00313404, a NA study of Healthy, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target
1
Study location

Study Summary

Norwalk virus and related "Norwalk-like viruses" are the most common cause of outbreaks of stomach sickness (nausea, vomiting, diarrhea) in older children and adults in the United States. These viruses are sometimes found in drinking water, ice, shellfish and in other foods. They can be spread easily from contact with water, food, objects or hands that have even small amounts of feces from someone who was sick. The purpose of this research study is to see how long Norwalk virus can survive in water and still be able to cause sickness. When this is determined the researchers will be able to recommend risk levels for norovirus contaminated waters. Another purpose for this study is to see how a person's body's immune cells respond to Norwalk virus in the body. During this study volunteers will receive a dose of Norwalk virus in water that may make them sick.

Conditions Studied

Interventions

  • BIOLOGICAL Safety tested norovirus inoculum

Study Locations (1)

Georgia

  • Emory University General Clinical Research Center - Atlanta

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2006-02
Est. Completion 2011-04
Phase NA
Emory University

1,208 total trials

What the finished NCT00313404 record still lists

NCT00313404 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Safety tested norovirus inoculum is the first listed.

NCT00313404 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT00313404 about?

NCT00313404 is a clinical study titled "Infectivity of Norovirus in Groundwater-Human Challenge Study". Norwalk virus and related "Norwalk-like viruses" are the most common cause of outbreaks of stomach sickness (nausea, vomiting, diarrhea) in older children and adults in the United States. These viruses are sometimes found in drinking water, ice, shellfish and in other foods. They can be spread easil...

What is the current status of trial NCT00313404?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2006-02. Estimated completion is 2011-04.

What conditions does trial NCT00313404 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00313404?

The interventions under investigation include: Safety tested norovirus inoculum (BIOLOGICAL).

Who is sponsoring clinical trial NCT00313404?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00313404 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00313404's enrollment target sits among peer trials

13 986th of 1090 higher than 96 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00313404, the US trial registry maintained by the National Library of Medicine. NCT00313404 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.